Skip to content

Christine Mikail Cvijic, President and CFO at Neurogene, sold NGNE on Jul 2, 2026

Data as of Oct 27

▼ SELL$87.5K2,531 shares at $34.58Christine Mikail Cvijic President and CFONGNE Neurogene Inc.
Watch NGNE
Traded
Jul 2, 2026
Disclosed
Jul 2, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Christine Mikail Cvijic, President and CFO at Neurogene, sold NGNE on Jul 2, 2026TRADEDDISCLOSED
NGNESimilar stocks (XLV — its sector index fund), rebased to NGNE's price on the disclosure day
NGNE since disclosure
−23.6%
after the sale
Similar stocks (XLV) since disclosure
+9.4%
XLV — its sector index fund

Change in closing price from Jul 2, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLChristine Mikail Cvijic President and CFONGNE Neurogene Inc.$53.9Kdisclosed Jul 2 · filed the same day
  2. ▼ SELLChristine Mikail Cvijic President and CFONGNE Neurogene Inc.$25.2Kdisclosed Jul 2 · filed 1 day after the trade

See every trade on NGNE →